Allium Financial Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$847K Sell
3,467
-37
-1% -$8.62K 0.68% 29
2025
Q4
$725K Sell
3,504
-4
-0.1% -$791 0.57% 31
2025
Q3
$650K Sell
3,508
-70
-2% -$12K 0.54% 31
2025
Q2
$547K Buy
3,578
+57
+2% +$8.76K 0.48% 34
2025
Q1
$584K Buy
+3,521
New +$551K 0.53% 33

Other funds holding JNJ

Allium Financial Advisors's JNJ Position: Q1 2026 in Review

Allium Financial Advisors reduced its Johnson & Johnson (JNJ) stake by 1.1% in Q1 2026, selling an estimated $8.62K and leaving 3,467 shares worth $847K. The position accounts for 0.68% of the portfolio, ranked #29.

Allium Financial Advisors first reported a position in JNJ in Q1 2025 and has held it in 5 quarters since. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Allium Financial Advisors held 3,467 shares of Johnson & Johnson worth $847K as of Q1 2026.
  • Allium Financial Advisors sold 37 Johnson & Johnson shares in Q1 2026, an estimated $8.62K.
  • Johnson & Johnson made up 0.68% of Allium Financial Advisors's portfolio in Q1 2026, its #29 holding.
  • Allium Financial Advisors first reported a position in Johnson & Johnson in Q1 2025 and has held it in 5 quarters since.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Allium Financial Advisors's 13F filing for Q1 2026, filed 7 May 2026.